Controversies in the treatment of non-small cell lung cancer; adjuvant chemotherapy
Dediu, M.
Pneumologia 50(2): 115-117
2001
ISSN/ISBN: 2067-2993 PMID: 11584671 Document Number: 534882
Document emailed within 1 workday
Related Documents
Okamoto, T.; Ichinose, Y. 2005: Postoperative adjuvant chemotherapy for non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(6): 765-769Marangolo, M.; Fiorentini, G. 1988: Adjuvant chemotherapy of non-small cell lung cancer: a review Seminars in Oncology 15(6 Suppl 7: 13-17
Grants, E.A.; Berzinia, V.I.; Bashko, I.I.; Zitare, I.I.; Berzin'sh, I.A. 1989: The results of the adjuvant chemotherapy of patients with small-cell lung cancer Voprosy Onkologii 35(2): 172-174
Cortes, J.; Rodriguez, J.; Calvo, E. 2001: Adjuvant chemotherapy for completely resected non-small-cell lung cancer New England Journal of Medicine 344(9): 689; Author Reply 690
Socinski, M.A. 1999: The current status of adjuvant chemotherapy for resected non-small cell lung cancer Seminars in Oncology 26(5 Suppl 15: 27-33
Hirai, Y.; Shimizu, Y.; Oura, S.; Yoshimasu, T.; Ota, F.; Nakamura, R.; Naito, K.; Nishiguchi, H.; Hashimoto, S.; Okamura, Y. 2012: The importance of p53 and ras mutation as predictive markers for adjuvant chemotherapy in non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 381-384
Uchida, T.; Nakakawaji, K.; Sakamoto, J. 1996: Administration of oral etoposide for one year as adjuvant chemotherapy for non-small cell lung cancer-side effect Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(14): 1967-1970
Hosokawa, Y.; Matsuge, S.; Murakami, Y.; Satoh, K.; Yamazaki, S.; Kan, T.; Hatakeyama, H. 2000: Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 53(11): 910-914
Yamaguchi, M.; Fukuyama, Y.; Ichinose, Y. 2003: Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 203-208
Momozane, T.; Higashiyama, M.; Maeda, J.; Okami, J.; Oda, K.; Imamura, F.; Yoneda, K.; Takenaka, A.; Kodama, K. 2009: Surgical treatment for the second double lung cancers following chemotherapy for small cell lung cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 62(2): 117-121
Hayakawa, K.; Mitsuhashi, N.; Saito, Y.; Takahashi, M.; Katano, S.; Shiojima, K.; Furuta, M.; Niibe, H. 1993: Effect of krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer Anticancer Research 13(5c): 1815-1820
Masuda, N. 1997: Combination chemotherapy in the treatment of inoperable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 3): 379-383
Shepherd, F.A. 2001: Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer Seminars in Oncology 28(2 Suppl 4: 30-37
Van Zandwijk, N.; Dalesio, O. 1994: Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer Seminars in Oncology 21(3 Suppl 6: 66-71
Ohnoshi, T.; Ueoka, H.; Hino, N.; Yonei, T.; Horiguchi, T.; Kiura, K.; Moritaka, T.; Kodani, T.; Kamei, H.; Segawa, Y. 1992: Treatment of small cell lung cancer in the elderly: the progress and limitation of chemotherapy Nihon Kyobu Shikkan Gakkai Zasshi 30(2): 216-223
Singer, Z.; Dzieza-Lalowicz, I.; Cieśla, J.; Kozaczka, A.; Rozek, K. 1986: Treatment of patients with small-cell lung cancer by the method of chemotherapy combined with Co-60 irradiation Polski Tygodnik Lekarski 41(23): 747-749
Ishiura, Y.; Yamamoto, H.; Terasaki, Y.; Ishida, Y.; Tohge, M.; Segawa, M.; Kusajima, Y.; Saitoh, K.; Ishikawa, M.; Hirokami, N.; Kasahara, K.; Fujimura, M. 2011: Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2631-2633
Bunn, P.A. 1999: Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer Seminars in Oncology 26(1 Suppl 4: 25-30
Armand, J.P. 2000: Docetaxel (Taxotere) in the treatment of non-small cell lung cancer (NSCLC)--is there a role for a new chemotherapy programme? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27 Suppl. 2: 223-230
Kaira, K.; Ishizuka, T.; Yanagitani, N.; Sunaga, N.; Hisada, T.; Mori, M. 2007: Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 225-227